Skip to content
Open access · CC-BY via OpenAlex

Recovery from Rapamycin

Stephanie K. Evans, Karl E. Burgess, Joseph V. Gray

Journal of Biological Chemistry · 2014 · ▲ 16 citations

Abstract

The target of mTOR(definition)-inhibiting drug studied for extending healthspan and lifespan." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">rapamycin(definition) complex 1 (TORC1) is a key conserved regulator of eukaryotic cell growth. The xenobiotic rapamycin is a potent inhibitor of the yeast complex. Surprisingly, the EGO complex, a nonessential in vivo activator of TORC1, is somehow required for yeast cells to recover efficiently from a period of treatment with rapamycin. Why? Here, we found that rapamycin is only a partial inhibitor of TORC1. We confirmed that saturating amounts of rapamycin do not fully inhibit proliferation of wild-type cells, and we found that the residual proliferation in the presence of the drug is dependent on the EGO complex and on the activity of TORC1. We found that this residual TORC1-dependent proliferation is key to recovery from rapamycin treatment. First, the residual proliferation rate correlates with the ability of cells to recover from treatment. Second, the residual proliferation rate persists long after washout of the drug and until cells recover. Third, the total observable pool of cell-associated rapamycin is extremely stable and decreases only with increasing cell number after washout of the drug. Finally, consideration of the residual proliferation rate alone accurately and quantitatively accounts for the kinetics of recovery of wild-type cells and for the nature and severity of the ego- mutant defect. Overall, our results revealed that rapamycin is a partial inhibitor of yeast TORC1, that persistence of the drug limits recovery, and that rapamycin is not detoxified by yeast but is passively diluted among progeny cells because of residual proliferation.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1074/jbc.m114.589754
Canonical
link ↗
Fetched
2026-10-08 MST

Cite this

APA
Evans, S.K., Burgess, K.E., &amp; Gray, J.V. (2014). Recovery from Rapamycin. <em>Journal of Biological Chemistry</em>. https://doi.org/10.1074/jbc.m114.589754
Vancouver
Evans SK, Burgess KE, Gray JV. Recovery from Rapamycin. Journal of Biological Chemistry. 2014. doi:10.1074/jbc.m114.589754.
BibTeX
@article{stephanie2014Recove, title = {Recovery from Rapamycin}, author = {Stephanie K. Evans and Karl E. Burgess and Joseph V. Gray}, journal = {Journal of Biological Chemistry}, year = {2014}, doi = {10.1074/jbc.m114.589754}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings